Detalhe da pesquisa
1.
Immune-related adverse events and disease outcomes after the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients receiving immune checkpoint inhibitors.
Cancer Immunol Immunother
; 72(10): 3217-3228, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37428196
2.
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world data.
Liver Int
; 43(8): 1803-1812, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37452505
3.
Role of enterocyte-specific gene polymorphisms in response to adjuvant treatment for stage III colorectal cancer.
Pharmacogenet Genomics
; 31(1): 10-16, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32732498
4.
Clinical significance of enterocyte-specific gene polymorphisms as candidate markers of oxaliplatin-based treatment for metastatic colorectal cancer.
Pharmacogenomics J
; 21(3): 285-295, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33542444
5.
Investigating the concordance in molecular subtypes of primary colorectal tumors and their matched synchronous liver metastasis.
Int J Cancer
; 147(8): 2303-2315, 2020 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32270478
6.
Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes.
Oncologist
; 25(6): 481-487, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31967692
7.
The heterogeneous clinical and pathological landscapes of metastatic Braf-mutated colorectal cancer.
Cancer Cell Int
; 20: 30, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32015690
8.
Genetic variants in CCL5 and CCR5 genes and serum VEGF-A levels predict efficacy of bevacizumab in metastatic colorectal cancer patients.
Int J Cancer
; 144(10): 2567-2577, 2019 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30411783
9.
CK7 and consensus molecular subtypes as major prognosticators in V600EBRAF mutated metastatic colorectal cancer.
Br J Cancer
; 121(7): 593-599, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31474758
10.
Another Chapter of the Right Versus Left Story: Is Primary Tumor Location a Prognostic Feature in RAS Mutant Metastatic Colorectal Cancer?
Oncologist
; 24(2): e77-e79, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30120156
11.
Early modifications of circulating microRNAs levels in metastatic colorectal cancer patients treated with regorafenib.
Pharmacogenomics J
; 19(5): 455-464, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30686821
12.
DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients.
Pharmacogenomics J
; 19(6): 556-563, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30723313
13.
Differential histopathologic parameters in colorectal cancer liver metastases resected after triplets plus bevacizumab or cetuximab: a pooled analysis of five prospective trials.
Br J Cancer
; 118(7): 955-965, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29531324
14.
Potential role of PIN1 genotypes in predicting benefit from oxaliplatin-based and irinotecan-based treatment in patients with metastatic colorectal cancer.
Pharmacogenomics J
; 18(5): 623-632, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29925895
15.
The PANDA study: a randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patients.
BMC Cancer
; 18(1): 98, 2018 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29370781
16.
Predictive value of TLR7 polymorphism for cetuximab-based chemotherapy in patients with metastatic colorectal cancer.
Int J Cancer
; 141(6): 1222-1230, 2017 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28569041
17.
Single nucleotide polymorphisms in the IGF-IRS pathway are associated with outcome in mCRC patients enrolled in the FIRE-3 trial.
Int J Cancer
; 141(2): 383-392, 2017 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28369940
18.
Tandem repeat variation near the HIC1 (hypermethylated in cancer 1) promoter predicts outcome of oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.
Cancer
; 123(22): 4506-4514, 2017 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28708932
19.
TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group.
BMC Cancer
; 17(1): 408, 2017 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28599628
20.
Clinico-pathological nomogram for predicting BRAF mutational status of metastatic colorectal cancer.
Br J Cancer
; 114(1): 30-6, 2016 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26575603